Showing results (1241-1250 of 1,787) with videos related to
Sort By:
Pageof 179
Hepatology Communications|May 16, 2025
Dynamics of HBV biomarkers during nucleos(t)ide analog treatment: A 14-year studyFlorian van Bömmel, Elisabetta Degasperi, Alena van Bömmel, et al.Hepatology Communications|May 16, 2025
Deletion of hepatic FXR leads to more severe MASH development in female miceZakiyah R Henry, Laura Armstrong, Syeda Maliha, et al.Hepatology Communications|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registryRichard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.Hepatology Communications|July 14, 2025
ORP2 regulates free cholesterol accumulation in hepatocytes during MASHJin Wu, Yudi Zhao, Liwen Qiu, et al.Hepatology Communications|July 14, 2025
The impact of BCLC recommendations on survival for patients with hepatocellular carcinomaMassimo Iavarone, Eleonora Alimenti, Lorenzo Canova, et al.Hepatology Communications|July 14, 2025
CRISPR-mediated proximity labeling unveils ABHD14B as a host factor to regulate HBV cccDNA transcriptional activityKazuma Sekiba, Nozomi Miyake, Yu Miyakawa, et al.Hepatology Communications|July 28, 2025
Integrating hepatology with addiction care for inpatients with alcohol use disorder reduces future liver-related eventsPaul George, Chantelle Marshall, Wei Zhang, et al.Hepatology Communications|July 21, 2025
Long-term outcomes after ICU admission in critically ill patients with liver cirrhosis: An Australian state-wide cohort studyDanny Con, William Kemp, Avik Majumdar, et al.Hepatology Communications|October 7, 2025
Paired snRNA-seq and scRNA-seq analysis of MASLD patients to identify early-stage markers for disease progressionSuebin Park, Su-Hyeon Lee, Se-Eun Han, et al.Hepatology Communications|October 16, 2025
Spatial heterogeneity in liver stiffness does not predict clinical outcomes in patients with primary sclerosing cholangitisErick Cruz Grave, Connie Chan, Michael T Corwin, et al.Pageof 179